Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19.
Clinical trial NCT04951349 · COMPLETED
Trial details
- NCT number
- NCT04951349
- Sponsor
- Turn Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-21
- Primary completion
- 2021-05-30
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.